Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001213900-25-093983
Filing Date
2025-09-30
Accepted
2025-09-30 16:30:29
Documents
19
Period of Report
2025-08-29
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM 8-K ea0258874-8ka1_cormedix.htm   iXBRL 8-K/A 43465
2 CONSENT OF EISNERAMPER LLP ea025887401ex23-1_cormedix.htm EX-23.1 2251
3 AUDITED CONSOLIDATED FINANCIAL STATEMENTS OF MELINTA AS OF AND FOR THE FISCAL YE ea025887401ex99-2_cormedix.htm EX-99.2 293904
4 UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS OF MELINTA AS OF AND FOR THE SIX MON ea025887401ex99-3_cormedix.htm EX-99.3 260972
5 UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION AS OF AND FOR THE Y ea025887401ex99-4_cormedix.htm EX-99.4 203833
6 GRAPHIC ex99-2_001.jpg GRAPHIC 7623
7 GRAPHIC ex99-2_002.jpg GRAPHIC 6346
8 GRAPHIC ex99-2_003.jpg GRAPHIC 1522
  Complete submission text file 0001213900-25-093983.txt   1120444

Data Files

Seq Description Document Type Size
9 XBRL SCHEMA FILE crmd-20250829.xsd EX-101.SCH 3014
10 XBRL LABEL FILE crmd-20250829_lab.xml EX-101.LAB 34239
11 XBRL PRESENTATION FILE crmd-20250829_pre.xml EX-101.PRE 22358
21 EXTRACTED XBRL INSTANCE DOCUMENT ea0258874-8ka1_cormedix_htm.xml XML 5007
Mailing Address 300 CONNELL DRIVE SUITE 4200 BERKELEY HEIGHTS NJ 07922
Business Address 300 CONNELL DRIVE SUITE 4200 BERKELEY HEIGHTS NJ 07922 908-517-9500
CorMedix Inc. (Filer) CIK: 0001410098 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-34673 | Film No.: 251360934
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)